TORONTO, ON (October 5, 2017) – Synaptive Medical, a leading Canadian medical device and technology company, announced today the appointment of veteran healthcare executive and current chairman of the board Peter Wehrly as chief executive officer. Cameron Piron will continue to serve as president and assume the new role of chief strategy officer.
As CEO, Peter’s primary focus will be on business operations, commercial execution, product development and execution to strategy. Cameron, as president and chief strategy officer, will focus on Synaptive’s long-term vision, strategic relationships, collaboration with employees and clients, investor relations and advanced research. Together, they will provide visionary and strategic leadership, as well as operational excellence in product development and commercialization.
For the full press release on the company website click here